Julie E. Buring, ScD
Adjunct Professor, Epidemiology - Boston University School of Public Health
Biography
Dr. Julie E. Buring is Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital; and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health.
The primary focus of her research is on the prevention of chronic diseases, especially among women. Dr. Buring has been involved in the design, conduct, analysis, and interpretation of a number of large-scale randomized clinical trials of the primary prevention of cardiovascular disease, cancer and other chronic diseases. These include the Women’s Health Study, evaluating the preventive roles of aspirin and vitamin E; the Physicians' Health Study II, evaluating vitamin E, vitamin C, beta-carotene, and a multivitamin; and VITAL, an ongoing trial of vitamin D and fish oil.
Dr. Buring is actively involved in the teaching and training of students and fellows in epidemiology, both nationally and internationally, and is co-Director of an NIH T32 training grant in the Epidemiology of Cardiovascular Disease. She serves as Chair of the Institutional Review Board of Harvard Medical School.
Education
- Harvard University, ScD Field of Study: Epidemiology
- University of Washington, MS Field of Study: Biostatistics
- Pomona College, BA Field of Study: Mathematics
Publications
- Published on 5/13/2026
Schulz RS, Glatz T, Buring JE, Kang JH, Kurth T, Rist PM. Cognitive decline and risk of all-cause mortality in older women: a cohort study. BMC Geriatr. 2026 May 13; 26(1). PMID: 42129690.
Read At: PubMed
- Published on 4/22/2026
Vergara C, Ni Z, Zhong J, McKean D, Connelly KE, Antwi SO, Arslan AA, Bracci PM, Du M, Gallinger S, Genkinger J, Haiman CA, Hassan M, Hung RJ, Huff C, Kooperberg C, Kastrinos F, LeMarchand L, Lee W, Lynch SM, Moore SC, Oberg AL, Park MA, Permuth JB, Risch HA, Scheet P, Schwartz A, Shu XO, Stolzenberg-Solomon RZ, Wolpin BM, Zheng W, Albanes D, Andreotti G, Bamlet WR, Beane-Freeman L, Berndt SI, Brennan P, Buring JE, Cabrera-Castro N, Campa D, Canzian F, Chanock SJ, Chen Y, Chung CC, Eliassen AH, Gaziano JM, Giles GG, Giovannucci EL, Goggins M, Goodman PJ, Hicks B, Hutchinson A, Jones MR, Katzke V, Kogevinas M, Kurtz RC, Laheru D, Lee IM, Malats N, Milne R, Mucci L, Neale RE, Orlow I, Patel AV, Peruchet L, Peters U, Porta M, Rabe KG, Real FX, Ricceri F, Rothman N, Sesso HD, Setiawan VW, Silverman D, Southey MC, Stampfer MJ, Tobias GS, Um C, Visvanathan K, Wactawski-Wende J, Wentzensen N, Willett WC, Yu H, Kraft P, Duggal P, Amundadottir LT, Klein AP. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals. medRxiv. 2026 Apr 22. PMID: 42078392.
Read At: PubMed
- Published on 3/2/2026
LeBoff MS, Chou SH, Ratnarajah DM, Cook NR, Khurana B, Kim E, Kotler G, Cawthon PM, Bauer DC, Black D, Gallagher JC, Lee IM, Buring JE, Manson JE. The effects of marine fatty acid omega-3 supplements on incident fractures and bone mineral density in generally healthy adults. J Bone Miner Res. 2026 Mar 02; 41(3):242-250. PMID: 41603552.
Read At: PubMed
- Published on 3/1/2026
Zhang T, Hua X, Mohindroo C, Wang X, Dutta D, Liu J, Katta S, Li SA, Wang J, Antwi SO, Arslan AA, Beane Freeman LE, Bracci PM, Canzian F, Du M, Gallinger S, Goodman PJ, Katzke V, Kooperberg C, Le Marchand L, Neale RE, Patel AV, Perdomo S, Shu XO, Visvanathan K, Van Den Eeden SK, White E, Zheng W, Albanes D, Andreotti G, Bamlet WR, Brennan P, Buring JE, Chanock SJ, Chen Y, Darst B, Ferrari P, Giovannucci EL, Goggins M, Haiman C, Hassan M, Holly EA, Hung RJ, Jones MR, Kraft P, Kurtz RC, Malats N, Moore SC, Ng K, Oberg AL, Orlow I, Peters U, Porta M, Rabe KG, Rothman N, Sánchez MJ, Sesso HD, Silverman DT, Southey MC, Um CY, Yarmolinsky J, Yu H, Yuan C, Zhong J, Wolpin BM, Risch HA, Amundadottir LT, Klein AP, Yu K, Zhang H, Stolzenberg-Solomon RZ. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. J Natl Cancer Inst. 2026 Mar 01; 118(3):437-447. PMID: 41206949.
Read At: PubMed
- Published on 2/1/2026
Nordestgaard AT, Chasman DI, Moorthy V, Kraaijenhof JM, Cook NR, Lee IM, Buring JE, Ridker PM. Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a). JAMA Cardiol. 2026 Feb 01; 11(2):175-185. PMID: 41499112.
Read At: PubMed
- Published on 1/16/2026
Ridker PM, Figtree GA, Moorthy MV, Mora S, Buring JE. C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the 'SMuRF-less but inflamed'. Eur Heart J. 2026 Jan 16; 47(3):306-314. PMID: 40878356.
Read At: PubMed
- Published on 11/1/2025
Nordestgaard AT, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE, Ridker PM. High-sensitivity C-reactive protein, LDL cholesterol, lipoprotein(a) and 30-year risk of stroke in healthy women: a prospective, longitudinal cohort study. Lancet Neurol. 2025 Nov; 24(11):920-930. PMID: 41109233.
Read At: PubMed
- Published on 10/23/2025
Watling CZ, Campbell PT, Graubard BI, Wang Y, Gewirtz AT, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Loftfield E, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Purdue MP, Sesso HD, Shrubsole M, Sinha R, Tinker L, Triplette M, Um CY, Visvanathan K, Watts EL, Wactawski-Wende J, Willett W, Wu F, Zheng W, Barupal D, Petrick JL, McGlynn KA. Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohorts. Int J Cancer. 2026 Apr 01; 158(7):1801-1812. PMID: 41129365.
Read At: PubMed
- Published on 9/5/2025
Duran EK, Cook NR, Aday AW, Buring JE, Ridker PM, Pradhan AD. Unsupervised Learning Analysis of Triglycerides, Inflammation, Cholesterol, and the Risks of Incident Cardiovascular Disease and Type 2 Diabetes in the Women's Health Study. J Am Heart Assoc. 2025 Sep 16; 14(18):e039381. PMID: 40913283.
Read At: PubMed
- Published on 9/1/2025
Watling CZ, Petrick JL, Graubard BI, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Loftfield E, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Palmer JR, Purdue MP, Rosenberg L, Sesso HD, Shrubsole M, Tinker L, Triplette M, Um CY, Visvanathan K, Watts EL, Wactawski-Wende J, Willett W, Wu F, Zheng W, Campbell PT, Barupal D, McGlynn KA. Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts. JNCI Cancer Spectr. 2025 Sep 01; 9(5). PMID: 40972035.
Read At: PubMed
View 887 more publications:View Full Profile at BUMC